FYI, I am at a net loss on this stock. The product concept does have potential and therapeutics have a lot of potential if they work. However, I will remain outside until these questions on the test are answered.
Is the current colorimetric format good enough to market by Abbott? If not, will they be able to improve it so that it will go to market?
Until the immediate threat of a product return goes away, I will not invest. In the meantime, I continue to watch and observe what management is doing to give me some idea what is going on. Right now, I am not pleased with what management is doing and I will continue to point out their follies.
I am also not a trader. I usually get to deeply involved in the analysis of a stock to be able to effectively trade. From that, I am either in or out and when I like one, I buy a lot.
News 
Market Data 
Discover 
